At the exit survey, participants were asked to report their satisfaction with the treatment and if they would use the study product again based on their experience in this study. Most participants (n = 91) were satisfied [n = 35 (34.31%)] or very satisfied [n = 59 (57.84%)] with treatment, and 93% of participants reported that they would use xylometazoline hydrochloride 0.1% again.